Recording of the Annual Meeting of Shareholders’ Speeches

Today’s Annual Meeting of Shareholders was mistakenly ended by the operator of the virtual platform after the formal part of the meeting. Speeches from Ms. Dawn Svoronos, Chair of the Board, and Mr. Paul Lévesque, President and Chief Executive Officer, which were supposed to be delivered during the informal part of the meeting, have been …Lire la suite

Theratechnologies a proud sponsor of NY AIDS WALK 2020

Theratechnologies was a proud sponsor of this year’s virtual NY AIDS WALK 2020 that went live on Sunday, June 7th at 10:00 AM EST! AIDS Walk New York is the largest single-day AIDS fundraising event in the world. In its 34 years, AIDS Walk New York has inspired nearly 890,000 people to walk and millions more to donate, …Lire la suite

Message from the President and CEO

As each and everyone of us is concerned with the current global pandemic, our goal at Theratechnologies remains, more than ever, to ensure that people living with HIV have access to our treatments. We have ample inventory to meet demand and our supply chain is up and running normally. People with an uncontrolled HIV are …Lire la suite

Theratechnologies responses to current COVID-19 pandemic

Ensuring patient access and product supply: Theratechnologies Inc. has enough inventory to provide TROGARZO®, EGRIFTA SVTM or EGRIFTA® to existing and new patients for the next 12 months. Production of TROGARZO®, EGRIFTA SVTM or EGRIFTA® has not been affected by the COVID-19 situation. The Department of Health and Human Services (DHHS) issued on Friday March …Lire la suite

A few words from Luc Tanguay

As I conclude my last few days as President and CEO of Theratechnologies, I want to express all my gratitude to shareholders, board members, management committee members as well past and present employees for the 23 wonderful years. I feel privileged to have had such an interesting and stimulating career at Theratechnologies and for the …Lire la suite

Nomination of Senior Director, Investor Relations

Theratechnologies is pleased to announce the nomination of Ms. Leah Gibson to the newly created position of Senior Director, Investor Relations.  Leah is a seasoned professional with over 17 years of experience in public company investor relations and financial communications.  Leah has spent the last seven years at Vertex Pharmaceuticals, a global biotechnology company with …Lire la suite